$NOTE

Down 29.3% in 4 Weeks, Here's Why FiscalNote Holdings, Inc. (NOTE) Looks Ripe for a Turnaround

FiscalNote Holdings, Inc. (NOTE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in ...

Original reporting
Zacks Commentary · Zacks Equity Research
Published Sep 16, 2025, 1:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 17, 2025, 1:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Down 29.3% in 4 Weeks, Here's Why FiscalNote Holdings, Inc. (NOTE) Looks Ripe for a Turnaround — source image
Decision brief

The 30-second read

$NOTENeutralMed
01

Why it matters

The oversold technical condition combined with analyst revisions suggests a possible short-term rebound, but caution is advised due to recent volatility.

02

Market read

The stock's recent decline and technical oversold status make it a candidate for a short-term trading opportunity, contingent on technical confirmation.

03

What to watch

Potential macroeconomic headwinds or sector-specific risks could negate technical signals; earnings surprises or negative news could alter the outlook.

Timing: Short-term (next 2-4 weeks)

Background

FiscalNote Holdings experienced a significant decline of approximately 29.3% over four weeks, driven by broader market sell-offs and company-specific factors.

Company-level read

Ticker impact

$NOTENeutralMedium confidence
Context

The article discusses FiscalNote Holdings, Inc. (NOTE), highlighting its oversold status and potential for a trend reversal.

Expected impact

Moderate upward price correction within the next 2-4 weeks.

Evidence & confidence

Oversold technical signals combined with positive analyst revisions indicate a potential rebound, though broader market conditions and company fundamentals should be monitored.

Market effects

The company's sector may experience increased investor interest if the turnaround materializes, potentially lifting sector ETFs.

Limited regional impact; primarily relevant to US-based investors.

Minimal global market influence unless broader tech or SaaS sectors rally.

Counterpoint

The oversold condition may be a result of underlying company issues not yet reflected in fundamentals; a further decline could occur if broader market sentiment worsens.

Key entities

  • FiscalNote Holdings, Inc.

    A provider of AI-enabled political and policy tracking solutions.

Related articles

$NOTEMed

FiscalNote Holdings, Inc. (NOTE): Results of Operations and Financial Condition

FiscalNote Holdings, Inc. (NOTE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 note-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 FiscalNote Reports Second Quarter 2026 Financial Results Total Revenue In Line with Guidance; Adjusted EBITDA Slightly Below Guidance; Establishes Q3 2026 Forecast and Revises FY26 Guidance Company To Host Conference Call Tod

$BKRMed

Baker Hughes to Supply Subsea Systems for Kutei Northern Hub

Baker Hughes said it won a contract to supply subsea production systems and digital solutions for the Kutei Northern Hub offshore Indonesia. The deal with Searah North Ganal, a subsidiary of Searah Limited (JV of Eni and Petronas), covers 17 deepwater horizontal tree systems plus manifolds, control and distribution equipment, and Cordant asset protection and condition monitoring.

$DISMed

Disney, Comcast reach deal, lifting NFL Network blackout

Comcast and Disney reached an agreement to end the NFL Network blackout for Comcast Xfinity TV subscribers, resuming NFL Network and NFL RedZone in time for the 2026 season. The blackout began after their contract expired in late April. Disney owns 72% of ESPN, which took over NFL Media assets earlier this year. Terms were not disclosed.

$ABUSMed

Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage?

Arbutus Biopharma (ABUS) received about $178 million from Moderna (MRNA) as its share of a $950 million noncontingent LNP patent settlement, with reimbursement of legal costs and an expected Q3 dividend tied to Genevant. ABUS reported Q1 2026 revenue of $179.1 million and net income of $169.7 million. Moderna reported Q2 2026 revenue of $145 million and a net loss of $782 million, plus FDA approval for mFLUSIVA.

$IONQMedAI 8/10

Pentagon may see one of quantum computing’s first practical winners

IonQ (IONQ) said DARPA awarded a $28 million contract modification under its It’s About Time program to support production development and 25 Evergreen-05 optical atomic clocks, with a $30 million option for 100 additional clocks. IonQ plans to invest $15 million to scale manufacturing. The company cites timing performance for GPS-denied defense uses.

$CCEYFMedAI 8/10

CanCambria Energy Provides Updated Contingent Resource Evaluation for Flagship Deep Gas Project, Attributable to Strong European Natural Gas Prices, Driving an Increased NPV10 of US$2.04 Billion

CanCambria Energy Corp. (TSXV: CCEC) reported an updated independent contingent resource evaluation for its 100% owned Kiskunhalas deep gas project in southern Hungary. Prepared by CHPE (effective June 30, 2026), it assumes $12.00/MMBtu TTF1 gas. Risked 2C Development Pending NPV10 rose 16% to US$2.04B from US$1.762B; 2C volumes are 571.9 Bcf and 59.6 MMbbl. First gas is targeted for mid-2027.